Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information [Yahoo! Finance]
Elite Pharmaceuticals, Inc. (ELTP)
NASDAQ:AMEX Investor Relations:
ir.elitepharma.com
Company Research
Source: Yahoo! Finance
Northvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the second quarter of fiscal year 2026 ended September 30, 2025 ("Second Quarter"). Consolidated revenues for the three-month period ending September 30, 2025, were $36.3 million, an increase of $17.4 million or approximately 92% as compared to the comparable period of the prior fiscal year. Income from operations was $8.2 million, an increase of $4.7 million or approximately 136%, as compared to the comparable period of the prior fiscal year. The increase in income from operations was primarily attributed to sales of Elite's lisdexamfetamine products, which were launched after the comparable period of the prior fiscal year, as well as overall strong growth in the Elite label product lines as compared to the comparable period in the prior fiscal year. Conferen
Show less
Read more
Impact Snapshot
Event Time:
ELTP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELTP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELTP alerts
High impacting Elite Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ELTP
News
- ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance [Yahoo! Finance]Yahoo! Finance
- Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Elite Pharmaceuticals Inc (ELTP) Q2 2026 Earnings Call Highlights: Surging Revenues and ... [Yahoo! Finance]Yahoo! Finance
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 [Yahoo! Finance]Yahoo! Finance
ELTP
Sec Filings
- 11/14/25 - Form 8-K
- 11/14/25 - Form 10-Q
- 11/12/25 - Form 8-K/A
- ELTP's page on the SEC website